Alfasigma S.p.a.
Clinical trials sponsored by Alfasigma S.p.a., explained in plain language.
-
New arthritis drug tested in kids for first time
Disease control Recruiting nowThis study is testing a medication called filgotinib in children and teenagers with juvenile idiopathic arthritis (JIA). The main goals are to see how the drug behaves in the body, if it's safe, and if kids can tolerate it. It's an early-phase study for children aged 8 to 18 whos…
Phase: PHASE1 • Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for kids with severe bowel disease
Disease control Recruiting nowThis study is testing a medication called filgotinib to see if it can help children and teenagers (ages 8 to 18) with moderate to severe ulcerative colitis. The main goals are to see if the drug can reduce symptoms, help patients achieve remission, and keep the disease under cont…
Phase: PHASE3 • Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC